Pierre Rocheteau
Overview
Explore the profile of Pierre Rocheteau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
980
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Serotonin reuptake inhibitors improve muscle stem cell function and muscle regeneration in male mice
Fefeu M, Blatzer M, Kneppers A, Briand D, Rocheteau P, Haroche A, et al.
Nat Commun
. 2024 Jul;
15(1):6457.
PMID: 39085209
Serotonin reuptake inhibitor antidepressants such as fluoxetine are widely used to treat mood disorders. The mechanisms of action include an increase in extracellular level of serotonin, neurogenesis, and growth of...
2.
Mascary J, Bordeau V, Nicolas I, Verdier M, Rocheteau P, Cattoir V
JAC Antimicrob Resist
. 2024 Feb;
6(1):dlae025.
PMID: 38410249
Objectives: Assessing the therapeutic potential of a novel antimicrobial pseudopeptide, Pep16, both and for the treatment of septic arthritis caused by . Methods: Seven clinical isolates of (two MRSA and...
3.
Chosidow S, Fantin B, Nicolas I, Mascary J, Chau F, Bordeau V, et al.
Antibiotics (Basel)
. 2023 Jan;
12(1).
PMID: 36671282
Colistin is a drug of last resort to treat extreme drug-resistant Enterobacterales, but is limited by dose-dependent toxicity and the emergence of resistance. A recently developed antimicrobial pseudopeptide, Pep16, which...
4.
Duceau B, Blatzer M, Bardon J, Chaze T, Giai Gianetto Q, Castelli F, et al.
Sci Rep
. 2022 Nov;
12(1):18776.
PMID: 36335235
Sepsis is defined as a dysregulated host response to infection leading to organs failure. Among them, sepsis induces skeletal muscle (SM) alterations that contribute to acquired-weakness in critically ill patients....
5.
Hardy D, Fefeu M, Besnard A, Briand D, Gasse P, Arenzana-Seisdedos F, et al.
Skelet Muscle
. 2019 Sep;
9(1):25.
PMID: 31533830
Background: During muscle regeneration, the chemokine CXCL12 (SDF-1) and the synthesis of some specific heparan sulfates (HS) have been shown to be critical. CXCL12 activity has been shown to be...
6.
Bougle A, Rocheteau P, Briand D, Hardy D, Verdonk F, Tremolada C, et al.
Muscle Nerve
. 2019 Jun;
60(3):328-335.
PMID: 31228273
Introduction: No etiologic therapy is available for Duchenne muscular dystrophy (DMD), but mesenchymal stem cells were shown to be effective in preclinical models of DMD. The objective of this study...
7.
Chatre L, Verdonk F, Rocheteau P, Crochemore C, Chretien F, Ricchetti M
Biochim Biophys Acta Mol Basis Dis
. 2017 May;
1863(10 Pt B):2546-2553.
PMID: 28456665
Sepsis is an acute systemic inflammatory response of the body to microbial infection and a life threatening condition associated with multiple organ failure. Survivors may display long-term disability with muscle...
8.
Loulergue P, Mir O, Rocheteau P, Chretien F, Gaillard R
Lancet Infect Dis
. 2016 Aug;
16(8):891.
PMID: 27477978
No abstract available.
9.
Bougle A, Rocheteau P, Sharshar T, Chretien F
Crit Care
. 2016 May;
20(1):131.
PMID: 27193340
Severe critical illness is often complicated by intensive care unit-acquired weakness (ICU-AW), which is associated with increased ICU and post-ICU mortality, delayed weaning from mechanical ventilation and long-term functional disability....
10.
Hardy D, Besnard A, Latil M, Jouvion G, Briand D, Thepenier C, et al.
PLoS One
. 2016 Jan;
11(1):e0147198.
PMID: 26807982
Background: A longstanding goal in regenerative medicine is to reconstitute functional tissues or organs after injury or disease. Attention has focused on the identification and relative contribution of tissue specific...